Koichi Sakaguchi

966 total citations
73 papers, 680 citations indexed

About

Koichi Sakaguchi is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Koichi Sakaguchi has authored 73 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 20 papers in Molecular Biology and 17 papers in Cancer Research. Recurrent topics in Koichi Sakaguchi's work include HER2/EGFR in Cancer Research (15 papers), Breast Cancer Treatment Studies (14 papers) and Breast Implant and Reconstruction (11 papers). Koichi Sakaguchi is often cited by papers focused on HER2/EGFR in Cancer Research (15 papers), Breast Cancer Treatment Studies (14 papers) and Breast Implant and Reconstruction (11 papers). Koichi Sakaguchi collaborates with scholars based in Japan, United States and Switzerland. Koichi Sakaguchi's co-authors include Naruhiko Mizuta, Tetsuya Taguchi, Ikuya Fujiwara, Hiroo Nakajima, Junji Magae, Katsuhiko Nakatsukasa, Soldano Ferrone, Takeshi Ishikawa, Meenhard Herlyn and Magdalena Eisinger and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Annals of Surgery.

In The Last Decade

Koichi Sakaguchi

68 papers receiving 661 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koichi Sakaguchi Japan 17 232 182 180 165 105 73 680
Mareyuki Endoh Japan 18 187 0.8× 306 1.7× 143 0.8× 158 1.0× 195 1.9× 33 786
Yasuhiro Yanagita Japan 14 296 1.3× 190 1.0× 421 2.3× 291 1.8× 95 0.9× 44 1.0k
San‐Gang Wu China 15 270 1.2× 206 1.1× 177 1.0× 365 2.2× 197 1.9× 41 886
Christina Finlayson United States 13 288 1.2× 153 0.8× 117 0.7× 303 1.8× 89 0.8× 29 634
In Ae Park South Korea 12 319 1.4× 186 1.0× 63 0.3× 241 1.5× 88 0.8× 18 605
Dimitrios Tryfonopoulos Greece 12 269 1.2× 176 1.0× 79 0.4× 119 0.7× 96 0.9× 46 627
Federica Zoratto Italy 11 323 1.4× 197 1.1× 83 0.5× 164 1.0× 140 1.3× 38 608
Takaomi Suzuma Japan 17 306 1.3× 358 2.0× 164 0.9× 256 1.6× 148 1.4× 52 885
Lorenzo Ferrando Italy 15 177 0.8× 216 1.2× 104 0.6× 198 1.2× 111 1.1× 45 558
Samanta Sarti Italy 17 490 2.1× 205 1.1× 112 0.6× 209 1.3× 193 1.8× 46 803

Countries citing papers authored by Koichi Sakaguchi

Since Specialization
Citations

This map shows the geographic impact of Koichi Sakaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Sakaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Sakaguchi more than expected).

Fields of papers citing papers by Koichi Sakaguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichi Sakaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Sakaguchi. The network helps show where Koichi Sakaguchi may publish in the future.

Co-authorship network of co-authors of Koichi Sakaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Koichi Sakaguchi. A scholar is included among the top collaborators of Koichi Sakaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichi Sakaguchi. Koichi Sakaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konishi, Eiichi, Isao Yokota, Shogen Boku, et al.. (2024). Additional statin treatment enhances the efficacy of HER2 blockade and improves prognosis in Rac1-high/HER2-positive breast cancer. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(8). 167458–167458. 2 indexed citations
2.
3.
4.
5.
Tsujimoto, Masayuki, Kosuke Yamamoto, Ryo Shimizu, et al.. (2023). Risk Factors for Infusion Reactions in Patients with Breast Cancer Administered Trastuzumab Therapy. Biological and Pharmaceutical Bulletin. 46(7). 964–968. 1 indexed citations
6.
Ooe, Asako, et al.. (2023). Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib. Anticancer Research. 43(6). 2783–2789. 2 indexed citations
7.
Tsujimoto, Masayuki, et al.. (2022). Incidence and risk factors of infusion reactions in patients with breast cancer administered trastuzumab plus pertuzumab-based regimen. Cancer Chemotherapy and Pharmacology. 91(1). 25–31. 3 indexed citations
8.
9.
Nakatsukasa, Katsuhiko, et al.. (2018). [Experience of Fulvestrant for Hormone Receptor-Positive HER2-Negative Advanced and Metastatic Breast Cancer].. PubMed. 45(6). 949–954. 1 indexed citations
10.
Shiomoto, Akihiro, et al.. (2012). 日本,北海道,氷に覆われたサロマ湖ラグーンにおける大型珪藻類の早春の開花. Journal of the Marine Biological Association of the United Kingdom. 92(1). 29–37. 1 indexed citations
11.
Fujita, Yoshifumi, Naruhiko Mizuta, Koichi Sakaguchi, et al.. (2012). [A case of effective lapatinib/capecitabine therapy for HER2-positive breast cancer with multiple brain metastases].. PubMed. 39(11). 1699–702. 1 indexed citations
12.
Mizuta, Naruhiko, et al.. (2011). [A case of effective combination therapy with docetaxel, cyclophosphamide and trastuzumab as primary systemic therapy for locally advanced HER2-positive breast cancer].. PubMed. 38(9). 1491–4.
13.
Okoshi, Kae, Keiko Iwaisako, Koichi Sakaguchi, Hajime Kubo, & Masakazu Toi. (2010). . Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 19(1). 53–59. 1 indexed citations
14.
Kaneko, Kenichi, Koichi Sakaguchi, Masato Inoue, et al.. (2009). Vibration of the Vocal Folds Observed Using a High-speed Movie System with Consumer Digital Video Camera. Practica Oto-Rhino-Laryngologica. 102(5). 379–384. 2 indexed citations
15.
Nakajima, Hiroo, Ikuya Fujiwara, Naruhiko Mizuta, et al.. (2008). Prognosis of Japanese Breast Cancer Based on Hormone Receptor and HER2 Expression Determined by Immunohistochemical Staining. World Journal of Surgery. 32(11). 2477–2482. 9 indexed citations
16.
Sakaguchi, Koichi, et al.. (2008). . Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 17(2). 154–160. 1 indexed citations
17.
Nakajima, Hiroo, Ikuya Fujiwara, Naruhiko Mizuta, et al.. (2007). INVESTIGATION OF THE PROGNOSIS OF BREAST CANCER FROM THE VIEW POINT OF PRESENTATION OF ESTROGEN RECEPTOR AND HER2 IN IMMUNOHISTOCHEMICAL STAINING. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 68(9). 2171–2177. 2 indexed citations
18.
Sawai, Kiyoshi, et al.. (2007). . Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 16(1). 38–43. 1 indexed citations
19.
Nakajima, Hiroo, Naruhiko Mizuta, Katsuhiko Nakatsukasa, et al.. (2006). [A case of multi-drug resistant recurrent breast cancer with multiple bone metastasis responding to TS-1 and trastuzumab].. PubMed. 33(9). 1305–8. 1 indexed citations
20.
Sawai, Kiyoshi, et al.. (2005). [Progress in endoscopic surgery for breast cancer].. PubMed. 32(9). 1240–3. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mareyuki Endoh Breakdown of academic impact, for papers by Yasuhiro Yanagita Breakdown of academic impact, for papers by San‐Gang Wu Breakdown of academic impact, for papers by Christina Finlayson Breakdown of academic impact, for papers by In Ae Park Breakdown of academic impact, for papers by Dimitrios Tryfonopoulos Breakdown of academic impact, for papers by Federica Zoratto Breakdown of academic impact, for papers by Takaomi Suzuma Breakdown of academic impact, for papers by Lorenzo Ferrando Breakdown of academic impact, for papers by Samanta Sarti
Rankless by CCL
2026